AstraZeneca To Buy US BioTech Biz For Up To $320M
AstraZeneca said on Tuesday that it will buy biotechnology company Neogene Therapeutics Ltd. for up to $320 million, as the pharmaceutical giant seeks to improve its cellular-level cancer treatments....To view the full article, register now.
Already a subscriber? Click here to view full article